<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="201305">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00469313</url>
  </required_header>
  <id_info>
    <org_study_id>L1234</org_study_id>
    <nct_id>NCT00469313</nct_id>
  </id_info>
  <brief_title>Efficacy of Inspiratory Muscle Training on Inspiratory Capacity in Patients With COPD</brief_title>
  <official_title>Efficacy of Inspiratory Muscle Training on Inspiratory Capacity in Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Hietzing</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Hietzing</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hypothesis:benefits of inspiratory muscle strenght training with Respifit S decreases
      symptoms, disability or handicap of patients affected by COPD. The inspiratory fraction
      (inspiratory capacity IC/ total lung capacity TLC)may be functionally more representative
      than other traditional indices.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Enrolling by invitation</last_known_status>
  <start_date>May 2007</start_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <condition>COPD</condition>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  COPD GOLD II-III (FEV1&lt;80 and &gt;30%)

        Exclusion Criteria:

          -  Pregnancy

          -  Lung cancer

          -  Diabetes mellitus

          -  Primary exacerbation of COPD
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Reiter</last_name>
    <role>Study Chair</role>
    <affiliation>Hospital Hietzing, A 1130, Vienna, Austria</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Hietzing</name>
      <address>
        <city>Vienna</city>
        <zip>1130</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>May 2008</verification_date>
  <lastchanged_date>May 21, 2008</lastchanged_date>
  <firstreceived_date>May 2, 2007</firstreceived_date>
  <keyword>copd</keyword>
  <keyword>inspiratory muscle training</keyword>
  <keyword>IF</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Respiratory Aspiration</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
